Glufosinate

Glufosinate

Global Glufosinate Market to Reach US$4.5 Billion by 2030

The global market for Glufosinate estimated at US$2.6 Billion in the year 2023, is expected to reach US$4.5 Billion by 2030, growing at a CAGR of 7.9% over the analysis period 2023-2030. Genetically Modified Crop, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$3.4 Billion by the end of the analysis period. Growth in the Conventional Crop segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$690.8 Million While China is Forecast to Grow at 11.7% CAGR

The Glufosinate market in the U.S. is estimated at US$690.8 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 11.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Glufosinate Market - Key Trends and Drivers Summarized

Why Is Glufosinate Becoming a Crucial Component in Modern Agriculture and Weed Management?

Glufosinate is emerging as a vital tool in modern agriculture due to its effectiveness as a non-selective herbicide, helping farmers manage weed control across a variety of crops. But why is glufosinate so essential today? Glufosinate works by inhibiting the enzyme glutamine synthetase in plants, leading to the accumulation of ammonia and eventual plant death. It is used to control a wide range of annual and perennial weeds, particularly those that have developed resistance to other herbicides like glyphosate. As herbicide resistance becomes a growing concern in agriculture, glufosinate provides an alternative, offering broad-spectrum weed control and improving crop yields.

In addition to its use as a herbicide, glufosinate is highly valued in integrated pest management systems for its role in pre-planting, post-emergence, and desiccation applications. Its effectiveness in controlling weeds before planting ensures that crops face less competition for nutrients, water, and sunlight during critical growth phases. Glufosinate is also praised for its relatively short soil persistence, which reduces the risk of environmental contamination compared to longer-lasting herbicides. As the agricultural industry strives to meet growing global food demands while addressing environmental concerns, glufosinate has become a crucial component in weed management strategies across various farming systems.

How Are Technological Advancements Improving the Application and Effectiveness of Glufosinate?

Technological advancements are significantly enhancing the application and effectiveness of glufosinate, making it more efficient, precise, and sustainable for modern agriculture. One of the key innovations is the development of advanced formulation technologies that improve the herbicide`s efficacy while reducing the amount needed. These formulations allow glufosinate to better adhere to plant surfaces and remain active for longer periods, leading to more consistent weed control, even under challenging environmental conditions such as rain or extreme temperatures. This results in fewer reapplications, reducing labor costs and minimizing the amount of chemical used.

Another important advancement is the integration of precision agriculture technologies, such as GPS-guided sprayers and drones, which allow farmers to apply glufosinate more accurately. These technologies enable targeted herbicide applications, reducing waste and limiting exposure to non-target plants or surrounding ecosystems. Precision application also lowers the chances of herbicide runoff or drift, addressing environmental concerns and ensuring that the herbicide reaches the intended weeds. As a result, farmers can reduce their overall herbicide usage while maintaining high levels of weed control.

The development of herbicide-tolerant crop varieties, such as genetically modified crops resistant to glufosinate, has also revolutionized its application. These crops can withstand applications of glufosinate without being harmed, allowing farmers to apply the herbicide more liberally for post-emergence weed control. This technology is particularly important in areas where weeds have developed resistance to other herbicides, providing a critical alternative in integrated weed management systems. By combining herbicide-tolerant crops with glufosinate applications, farmers can manage weeds more effectively while minimizing crop damage and maximizing yields.

Biotechnological advances are also enhancing the environmental profile of glufosinate by improving its biodegradability. Researchers are working on optimizing glufosinate formulations to break down more quickly in the environment, reducing the risk of soil or water contamination. These improvements make glufosinate a more environmentally responsible choice for farmers concerned about the long-term ecological impact of herbicide use. Additionally, the ongoing development of bioherbicides, which integrate natural compounds with synthetic ones like glufosinate, offers the potential for even more sustainable weed control solutions in the future.

Why Is Glufosinate Critical for Addressing Herbicide Resistance and Supporting Sustainable Farming Practices?

Glufosinate is critical for addressing the growing challenge of herbicide resistance and supporting sustainable farming practices because it offers an alternative mode of action for controlling resistant weed species. Over the past several decades, the overuse of herbicides like glyphosate has led to the development of herbicide-resistant weeds, which pose a significant threat to crop yields and farm productivity. Weeds such as pigweed, ragweed, and horseweed have become increasingly resistant to glyphosate, reducing its effectiveness and forcing farmers to look for other options. Glufosinate, with its different mode of action, provides an effective solution to combat these resistant weeds, helping farmers protect their crops and maintain high yields.

By offering a new tool for weed control, glufosinate helps delay the further development of resistance. It is often used in rotation with other herbicides as part of an integrated weed management strategy, which involves alternating herbicides with different modes of action to prevent weeds from developing resistance to any one product. This rotation strategy is essential for maintaining the long-term viability of herbicides and ensuring that farmers have effective tools to manage weeds. Without alternatives like glufosinate, herbicide resistance could become a more severe and widespread problem, leading to increased costs for farmers and reduced agricultural productivity.

Glufosinate also supports sustainable farming practices by contributing to reduced tillage or no-till farming systems. In these systems, herbicides like glufosinate are used to control weeds without the need for mechanical soil disturbance. No-till farming has numerous environmental benefits, including reduced soil erosion, improved water retention, and enhanced soil health. By minimizing soil disturbance, farmers can protect vital soil ecosystems and improve the long-term sustainability of their operations. Glufosinate’s effectiveness as a pre-plant and post-emergence herbicide makes it an essential tool in these conservation agriculture practices.

Additionally, glufosinate’s relatively short environmental persistence makes it a more environmentally friendly herbicide option. Its ability to break down quickly in the soil reduces the risk of long-term environmental contamination, making it safer for nearby water sources and non-target organisms. This aligns with the growing demand for sustainable and environmentally responsible farming practices, particularly in regions where herbicide use is tightly regulated. Farmers who are looking to balance effective weed control with environmental stewardship increasingly turn to glufosinate as a solution that meets both their agricultural and ecological goals.

What Factors Are Driving the Growth of the Glufosinate Market?

Several key factors are driving the rapid growth of the glufosinate market, including the increasing prevalence of herbicide-resistant weeds, rising demand for sustainable agricultural practices, the expansion of herbicide-tolerant crops, and advancements in herbicide formulations and application technologies. First, the growing problem of herbicide-resistant weeds is a major driver of the glufosinate market. As glyphosate and other commonly used herbicides become less effective against resistant weed species, farmers are seeking alternative solutions to maintain crop yields and manage weed populations. Glufosinate offers a different mode of action, making it an effective tool for controlling resistant weeds and delaying the further spread of resistance.

Second, the rising demand for sustainable agricultural practices is boosting the adoption of glufosinate. As consumers and regulators increasingly prioritize environmental sustainability, farmers are under pressure to use herbicides that have a lower impact on the environment. Glufosinate’s relatively short soil persistence and ability to integrate into no-till farming systems make it a favorable option for environmentally conscious farmers. Additionally, as more countries and regions implement stricter regulations on herbicide use, the demand for safer, biodegradable herbicides like glufosinate is expected to increase.

The expansion of herbicide-tolerant genetically modified (GM) crops is another significant factor driving the glufosinate market. Crops such as corn, soybeans, and cotton that are engineered to tolerate glufosinate applications are becoming more widespread, particularly in regions where herbicide-resistant weeds are a growing concern. These GM crops allow farmers to apply glufosinate during critical growth stages without damaging the plants, providing an efficient solution for weed management. As the global adoption of GM crops continues to rise, the demand for glufosinate is expected to grow in parallel.

Advancements in herbicide formulations and application technologies are also contributing to the growth of the glufosinate market. New formulations that improve the stability, adherence, and efficacy of glufosinate are making it easier for farmers to achieve consistent results with fewer applications. Additionally, precision agriculture technologies, such as GPS-guided sprayers and drone-based herbicide delivery systems, are enabling more targeted applications of glufosinate, reducing waste and minimizing the environmental impact. These innovations are helping farmers use glufosinate more efficiently, lowering costs and improving its effectiveness in the field.

Finally, the increasing global demand for food is driving the need for more efficient and sustainable agricultural practices. As the global population grows, farmers are under pressure to produce higher yields on existing farmland. Effective weed control is critical to achieving these yield goals, and herbicides like glufosinate play a key role in ensuring that crops are not outcompeted by weeds. The ability of glufosinate to improve crop productivity while supporting sustainable farming practices positions it as an essential tool for meeting the world’s growing food demands.

In conclusion, the growth of the glufosinate market is being driven by the rising prevalence of herbicide-resistant weeds, the demand for sustainable agricultural practices, the expansion of herbicide-tolerant crops, and advancements in herbicide formulations and application technologies. As the agricultural industry continues to prioritize efficiency, sustainability, and environmental responsibility, glufosinate will play an increasingly important role in modern weed management and crop production systems.

Select Competitors (Total 44 Featured) -
  • Bayer AG
  • Bayer CropScience AG
  • Dow, Inc.
  • DuPont de Nemours, Inc.
  • Jiangsu Huangma Agrochemicals Co., Ltd.
  • Jiangsu Sevencontinent Green Chemical Co., Ltd.
  • LIER Chemical Co., Ltd.
  • Nufarm Limited
  • Syngenta AG
  • UPL Ltd.
  • Veyong (Hebei Veyong Bio-Chemical Co. Ltd)
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Global Economic Update
Glufosinate – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Demand for Non-selective Herbicides Drives Glufosinate Market Growth
Innovations in Crop Biotechnology Promoting the Use of Glufosinate-Tolerant Genetically Modified Crops
Growing Concerns Over Glyphosate Resistance Leading to Increased Use of Alternatives
Market Opportunities in Integrated Weed Management Systems
Future Directions: Development of Eco-friendly and Biodegradable Herbicides
Expansion of Glufosinate Use in Non-agricultural Settings such as Parks and Urban Areas
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Glufosinate Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Glufosinate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Glufosinate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Glufosinate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Genetically Modified by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Genetically Modified by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Genetically Modified by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Conventional by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Conventional by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Conventional by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Liquid Formulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Liquid Formulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Liquid Formulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Dry Formulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Dry Formulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Dry Formulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Agricultural by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Agricultural by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Agricultural by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Non-Agricultural by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Non-Agricultural by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Non-Agricultural by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 23: USA Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 24: USA Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 25: USA 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 26: USA Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 27: USA Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 28: USA 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 29: USA Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 30: USA Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: USA 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
CANADA
TABLE 32: Canada Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 33: Canada Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: Canada 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 35: Canada Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: Canada Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: Canada 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 38: Canada Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: Canada Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: Canada 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
JAPAN
Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 41: Japan Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: Japan Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: Japan 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 44: Japan Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: Japan Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: Japan 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 47: Japan Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: Japan Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: Japan 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
CHINA
Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 50: China Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: China Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: China 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 53: China Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: China Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: China 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 56: China Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: China Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: China 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
EUROPE
Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 59: Europe Recent Past, Current & Future Analysis for Glufosinate by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 60: Europe Historic Review for Glufosinate by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: Europe 16-Year Perspective for Glufosinate by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 62: Europe Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: Europe Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: Europe 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 65: Europe Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: Europe Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: Europe 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 68: Europe Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Europe Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: Europe 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
FRANCE
Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 71: France Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: France Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: France 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 74: France Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: France Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: France 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 77: France Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: France Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: France 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
GERMANY
Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 80: Germany Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: Germany Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: Germany 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 83: Germany Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: Germany Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: Germany 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 86: Germany Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Germany Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Germany 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
ITALY
TABLE 89: Italy Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Italy Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Italy 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 92: Italy Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Italy Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Italy 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 95: Italy Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: Italy Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Italy 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
UNITED KINGDOM
Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 98: UK Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: UK Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: UK 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 101: UK Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: UK Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: UK 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 104: UK Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 105: UK Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: UK 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
SPAIN
TABLE 107: Spain Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 108: Spain Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 109: Spain 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 110: Spain Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 111: Spain Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 112: Spain 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 113: Spain Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 114: Spain Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 115: Spain 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
RUSSIA
TABLE 116: Russia Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 117: Russia Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 118: Russia 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 119: Russia Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 120: Russia Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 121: Russia 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 122: Russia Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 123: Russia Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 124: Russia 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 126: Rest of Europe Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 127: Rest of Europe 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 129: Rest of Europe Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 130: Rest of Europe 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 132: Rest of Europe Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 133: Rest of Europe 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Glufosinate by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 135: Asia-Pacific Historic Review for Glufosinate by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 136: Asia-Pacific 16-Year Perspective for Glufosinate by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 138: Asia-Pacific Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 139: Asia-Pacific 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 141: Asia-Pacific Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 142: Asia-Pacific 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 144: Asia-Pacific Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 145: Asia-Pacific 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
AUSTRALIA
Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 146: Australia Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 147: Australia Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 148: Australia 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 149: Australia Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 150: Australia Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 151: Australia 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 152: Australia Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 153: Australia Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 154: Australia 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
INDIA
Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 155: India Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 156: India Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 157: India 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 158: India Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 159: India Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 160: India 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 161: India Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 162: India Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 163: India 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 164: South Korea Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 165: South Korea Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 166: South Korea 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 167: South Korea Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 168: South Korea Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 169: South Korea 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 170: South Korea Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 171: South Korea Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 172: South Korea 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 173: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 174: Rest of Asia-Pacific Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 175: Rest of Asia-Pacific 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 177: Rest of Asia-Pacific Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 178: Rest of Asia-Pacific 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 180: Rest of Asia-Pacific Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
LATIN AMERICA
Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 182: Latin America Recent Past, Current & Future Analysis for Glufosinate by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 183: Latin America Historic Review for Glufosinate by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 184: Latin America 16-Year Perspective for Glufosinate by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 185: Latin America Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 186: Latin America Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 187: Latin America 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 188: Latin America Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 189: Latin America Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 190: Latin America 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 191: Latin America Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 192: Latin America Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 193: Latin America 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 194: Argentina Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 195: Argentina Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 196: Argentina 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 197: Argentina Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 198: Argentina Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 199: Argentina 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 200: Argentina Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 201: Argentina Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 202: Argentina 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
BRAZIL
TABLE 203: Brazil Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 204: Brazil Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 205: Brazil 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 206: Brazil Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 207: Brazil Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 208: Brazil 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 209: Brazil Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 210: Brazil Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 211: Brazil 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
MEXICO
TABLE 212: Mexico Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 213: Mexico Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 214: Mexico 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 215: Mexico Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 216: Mexico Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 217: Mexico 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 218: Mexico Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 219: Mexico Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 220: Mexico 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 221: Rest of Latin America Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 222: Rest of Latin America Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 223: Rest of Latin America 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 225: Rest of Latin America Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 226: Rest of Latin America 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 228: Rest of Latin America Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 229: Rest of Latin America 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
MIDDLE EAST
Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 230: Middle East Recent Past, Current & Future Analysis for Glufosinate by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 231: Middle East Historic Review for Glufosinate by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 232: Middle East 16-Year Perspective for Glufosinate by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 233: Middle East Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 234: Middle East Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 235: Middle East 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 236: Middle East Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 237: Middle East Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 238: Middle East 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 239: Middle East Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 240: Middle East Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 241: Middle East 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
IRAN
TABLE 242: Iran Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 243: Iran Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 244: Iran 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 245: Iran Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 246: Iran Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 247: Iran 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 248: Iran Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 249: Iran Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 250: Iran 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
ISRAEL
TABLE 251: Israel Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 252: Israel Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 253: Israel 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 254: Israel Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 255: Israel Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 256: Israel 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 257: Israel Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 258: Israel Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 259: Israel 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 260: Saudi Arabia Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 261: Saudi Arabia Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 262: Saudi Arabia 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 264: Saudi Arabia Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 265: Saudi Arabia 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 267: Saudi Arabia Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 268: Saudi Arabia 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 269: UAE Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 270: UAE Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 271: UAE 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 272: UAE Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 273: UAE Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 274: UAE 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 275: UAE Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 276: UAE Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 277: UAE 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 278: Rest of Middle East Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 279: Rest of Middle East Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 280: Rest of Middle East 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 282: Rest of Middle East Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 283: Rest of Middle East 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 285: Rest of Middle East Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 286: Rest of Middle East 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
AFRICA
Glufosinate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 287: Africa Recent Past, Current & Future Analysis for Glufosinate by Crop Type - Genetically Modified and Conventional - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 288: Africa Historic Review for Glufosinate by Crop Type - Genetically Modified and Conventional Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 289: Africa 16-Year Perspective for Glufosinate by Crop Type - Percentage Breakdown of Value Sales for Genetically Modified and Conventional for the Years 2014, 2024 & 2030
TABLE 290: Africa Recent Past, Current & Future Analysis for Glufosinate by Form - Liquid Formulation and Dry Formulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 291: Africa Historic Review for Glufosinate by Form - Liquid Formulation and Dry Formulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 292: Africa 16-Year Perspective for Glufosinate by Form - Percentage Breakdown of Value Sales for Liquid Formulation and Dry Formulation for the Years 2014, 2024 & 2030
TABLE 293: Africa Recent Past, Current & Future Analysis for Glufosinate by Application - Agricultural and Non-Agricultural - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 294: Africa Historic Review for Glufosinate by Application - Agricultural and Non-Agricultural Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 295: Africa 16-Year Perspective for Glufosinate by Application - Percentage Breakdown of Value Sales for Agricultural and Non-Agricultural for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings